Maxalt
RxNorm concept 218248, brand name (bn).
- RxCUI
- 218248
- Term type
- Brand name (BN)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/218248 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- rizatriptan benzoate (PIN, has precise ingredient)
- rizatriptan 10 MG Oral Tablet [Maxalt] (SBD, ingredient of)
- rizatriptan Oral Tablet [Maxalt] (SBDF, ingredient of)
- rizatriptan 10 MG [Maxalt] (SBDC, ingredient of)
- rizatriptan Disintegrating Oral Tablet [Maxalt] (SBDF, ingredient of)
- rizatriptan 10 MG Disintegrating Oral Tablet [Maxalt] (SBD, ingredient of)
- Maxalt Oral Product (SBDG, ingredient of)
- Maxalt Pill (SBDG, ingredient of)
- Maxalt Disintegrating Oral Product (SBDG, ingredient of)
- rizatriptan (IN, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 218248 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/218248 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 218248. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.